Iridian Asset Management Raises Stake in Enzon Pharmaceuticals, Inc. (ENZN) to 11.6%

In a 13G filing on Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN), fund Iridian Asset Management disclosed a 11.6%, or 5,650,187 share, stake in the company. This is up 24.38% from the 4,542,530 shares held at the end of the latest quarter ending June 30, 2011.

For more notable holders of Enzon Pharmaceuticals, Inc. stock click here. For more information on Iridian Asset Management click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters
• TCIM accuses Voya Financial of blocking shareholder no-confidence vote
• Lionsgate faces activist pressure to sell itself in ‘AI era’ - Semafor